












Trends in University Ag-Biotech 
Patent Production 
 
By Bradford Barham, 
Jeremy Foltz,  
and Kwansoo Kim 
 
Food Marketing Policy Center 

























University of Connecticut 
















Trends in University Ag-Biotech  
Patent Production 
 




Food Marketing Policy Center 



























Department of Agricultural and Resource Economics 










1.  Introduction........................................................................................................................................1 
2.  Key Issues...........................................................................................................................................1 
2.1 Ag-Biotech Patenting Trends...........................................................................................................1 
2.2 Persistence.....................................................................................................................................1 
2.3 Determinants of Patenting Success...................................................................................................2 
2.4 University Research Spillovers........................................................................................................2 
2.5 Local Spillovers .............................................................................................................................2 
2.6 Inequality.......................................................................................................................................2 
 
3.  Data on Ag-Biotech Patenting.............................................................................................................3 
4.  Empirical Evidence.............................................................................................................................4 
4.1 Key Trends in U.S. University Ag-Biotech Patent Production............................................................3 
4.2 Who are the Leaders?......................................................................................................................3 
4.3 Persistence .....................................................................................................................................4 
4.4 Determinants of Patenting Success...................................................................................................4 
4.5 Citations—Quality, Spillovers and Local Spillovers..........................................................................5 
4.5.1 Quality..................................................................................................................................5 
4.5.2 Spillovers..............................................................................................................................5 
4.5.3 Local Spillovers.....................................................................................................................5 
4.6 Inequality in Patent Production Lorenz Curve Analysis.....................................................................6 
 
5.  Concluding Remarks ..........................................................................................................................6 
References ..................................................................................................................................................7 
Food Marketing Policy Center Research Report Series Ordering Information ..................................................14 
 
Tables 
Table 1.  University Ag-Biotech Patent Rankings ..........................................................................................8 
Table 2.  Citations by the Top 20 Patenting Universities.................................................................................9 





Figure 1. University Ag-Biotech Production by Year .....................................................................................11 
Figure 2. Average Citations per Patent by Year..............................................................................................11 
Figure 3. Lorenz Curves for Ag-Biotech Patents at Land Grant Universities ....................................................12 
Figure 4. Lorenz Curves for Citations Received in Land Grant Universities. ...................................................12 
Figure 5.  Lorenz Curves For Ag-Biotech Patents, Agricultural Graduate Students and Federal Funding in 












This project has been partially funded by generous grants from the Food Marketing Policy Center and the 
Research Foundation at the University of Connecticut and the Food Systems Research Group at the University of 
Wisconsin. Contact author: Bradford Barham, Dept. of Agricultural & Applied Economics,427 Lorch St., 








Authors in alphabetical order, no seniority assigned. Barham and Kim are respectively Associate Professor 
and Research Associate, Dept. of Ag. & Applied Economics, University of Wisconsin.  Foltz is an Assistant 
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1. Introduction 
 
Agricultural research has historically exhibited high 
rates of social return (Alston and Pardey), thereby 
bolstering the case for public support of research, 
especially at land-grant universities.  Recently, however, 
scholars and blue-ribbon review panels have expressed 
increasing concern that the Bayh-Dole Act, which 
allowed universities to sell exclusive licenses to their 
inventions, and agricultural biotechnology (ag-biotech) 
are part of a privatization of publicly sponsored 
agricultural research, which may reduce the social 
returns.  Examples of these concerns with the social 
welfare implications of new patterns of intellectual 
property rights management and conduct are explicated 
in many publications including a report by the National 
Association of State Universities and Land-Grant 
Colleges, an entire issue of AgBioForum, and books by 
Fuglie and Schimmelpfennig and by Wolf and 
Zilberman.   
At the heart of the controversy is the fact that 
agricultural research advances that universities used to 
publicly disseminate without charge may now be 
guarded as valuable secrets, patented to create 
intellectual property rights, and licensed or 
commercialized in concert with private firms under 
potentially monopolistic conditions (Weatherspon, 
Oehmke, and Raper).  While it is entirely appropriate 
that the normative (welfare) implications of these 
changes have been the predominant focus of the 
discussion, systematic evidence is still missing about the 
actual patterns of university patenting, citation, 
licensing, and other outcomes associated with ag-biotech 
research.   That is, there is a need for data that could help 
sharpen the focus of ongoing research and policy work 
in this arena around what is actually happening in the 
realm of ag-biotech research in U.S. universities.    
In particular, it would help to know the answers to 
issues such as: (1) What are the temporal trends in 
university patents, citations, and revenues from ag-
biotech research?  In terms of university research, are we 
in the midst of an ag-biotech revolution?  (2) Who are 
the leading universities in producing ag-biotech patents, 
securing citations, and earning revenues? (3) Is 
university leadership in this arena persistent over time or 
subject to major changes? (4) What are the main factors 
that explain university ag-biotech patent production, 
citations, and revenues?  (5) Is there evidence of local 
business or research spillovers from ag-biotech patents 
and citations as there has been in the pharmaceutical side 
of biotechnology research? (6) Overall, is ag-biotech 
research likely to deepen or reduce historical patterns of 
inequality in resources and capabilities within land-grant 
institutions?   
In this paper, we draw on U.S. patent and citation 
data to examine trends over the past twenty-five years in 
ag-biotech. The next section sets forth in more detail 
some key issues concerning patterns of university ag-
biotech patenting and citations.  Section 3 provides a 
careful description of the data used for the analysis.  The 
empirical analysis in Section 4 offers evidence on the 
evolving trends of university ag-biotech patenting and 
citations to help answer the key issues.  The paper closes 
by considering how the evidence offered might be used 
to advance the public discussion regarding the changes 
occurring in ag-biotech research in the U.S. 
 
2.   Key Issues  
 
In recent years, a number of key issues associated 
with university production of ag-biotech patents have 
been raised.  The time is ripe for an appraisal of the data 
in this arena to identify what we can say already and 
what needs further investigation.   
 
2.1 Ag-Biotech Patenting Trends  
Which universities are taking the lead in ag-biotech 
patenting and how many patents are they producing? 
While public debate on the merits of ag-biotech 
patenting has intensified, actual data on the number of 
ag-biotech patents produced and who is producing them 
have been non-existent.
1 Aside from knowing who has 
produced how many patents one might also ask whether 
Land Grant Universities are the leaders in ag-biotech 
patenting or whether due to complementarities with non-
agricultural biotech research other types of universities 
(e.g., Harvard and MIT) are major players.   
 
2.2 Persistence   
Does initial success in ag-biotech patenting produce 
the ability to do more patenting? Is there persistence in 
university patenting (and citations)?  If this were the 
case, universities who did not enter the ag-biotech patent 
game early would find it difficult to catch-up. In the 
literature on industry innovation, this persistence in 
innovation is often described as “deepening”.  The 
opposite dynamic would be a process of widening in 
                                                 
1 For example attempts by the authors to get accurate counts 
from university patent offices showed differing definitions and 
a fuzzy knowledge on the part of technology transfer 
personnel on what could be considered ag-biotech.  Also a 
recent conference of agricultural college Deans and Research 
directors concerned with ag-biotech issues included a heated, 
but data-free, discussion of who had more ag-biotech patents. Trends in University Ag-Biotech Patent Production  Barham, Foltz, and Kim 
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which over time more universities can participate in the 
production of ag-biotech patenting.  Patterns of widening 
are common when information flows easily across 
institutions and there are few barriers to entry, while 
patterns of deepening are common when there are 
constricted information flows and increasing returns in 
innovation production. 
A related concern is whether because of the 
incentive to patent universities and their scientists are 
acting more like competitive companies and withholding 
information from erstwhile competitors rather than like 
the knowledge generators and sharers they have 
historically been.  Of course many other things besides 
the degree of information sharing across universities will 
determine persistence, including heavy investment costs 
in laboratories, dynamic learning in the tech transfer 
process, and the like.  Thus, evidence of persistence, 
while it cannot be equated directly with problems of 
information flows, provides some suggestion as to 
whether it could be a problem. 
 
2.3 Determinants of Patenting Success 
What are the key determinants of ag-biotech 
patenting performance across universities?  How 
important is the land-grant effect (a history of agriculture 
related research)? Does industry financing matter? Are 
there identifiable synergies with biology departments? 
How important are technology transfer offices?  We 
augment the patent data used here with results from an 
econometric analysis developed in Foltz, Kim, and 
Barham to provide some initial answers to these 
questions. 
 
2.4 University Research Spillovers  
Are there significant economic spillovers to 
university ag-biotech patenting? While traditional 
agricultural research is well known to create significant 
spillovers both locally and nationally, the intellectual 
property rights associated with ag-biotech patenting 
create a different dynamic.  At issue is who uses and 
who benefits from patented ag-biotech innovations. 
Citation data offers evidence on the relative levels of 
usage of university patents in other patents from the 
same university, U.S. companies, other universities, and 
foreign companies.  Work by Jaffe, Trajtenberg, and 
Fogarty has also shown a significant correlation between 
patent citations and the economic and technological 
importance of patents.  
 
2.5 Local Spillovers 
Does university ag-biotech patenting produce 
spillovers that are locally appropriated within a state’s 
economy or is the research a national public good?   
Studies of pharmaceutical biotech (e.g. Audretsch and 
Stephan; Zucker, Darby and Brewer) find evidence that 
university research has generated industry clusters 
concentrated around major research universities due to 
knowledge spillovers into local companies as well as the 
creation of start-up companies based on university 
technology.  Recent work on ag-biotech (e.g. Zilberman, 
Yarkin, and Heiman; Foltz, Barham and Kim) has 
tended to presume that ag-biotech research will produce 
a strong pattern of local spillovers from universities.   
  Many states have started to invest heavily in 
promoting ag-biotech research capacity in order to take 
advantage of these perceived agglomeration economies 
or local spillovers.  In the case of ag-biotech, the 
technology may have national or international rather 
than local adoption patterns and be produced by 
dominant global firms, thus undercutting in two ways 
the logic of public investment in university research for 
the purpose of generating local economic spillovers. The 
citations data used here offer preliminary evidence on 
the geography of economic spillovers from ag-biotech 
patenting by addressing whether university ag-biotech 
patents foster more ag-biotech research by in-state 
companies or out-of-state companies. 
 
 
2.6 Inequality  
Does ag-biotech patenting generate inequalities 
among universities?  One of the arguments for allowing 
universities to patent their innovations is the incentive 
provided by the potential for revenues from those 
patents.  Some observers (Ohmke et al.) have worried 
that ag-biotech patenting may become a lucrative 
revenue stream only available to the larger, more 
research oriented Land Grant Universities leaving 
smaller universities at a disadvantage in this and other 
arenas.  The patent data are used to provide evidence on 
the levels of inequality of patent production, which is 
then compared with levels of inequalities in graduate 
student enrollments and agricultural research funding.   
Citation data are also used to provide further evidence 






                                                 
2 While revenue data is not available, ag-biotech patent 
production maybe in too early a stage of production for it to be 
an accurate measure of value. Given the usual lag between 
patents and commercial development and the dramatic growth 
in the last four years, it is likely that revenues from these 
patents are still relatively low in most universities. Trends in University Ag-Biotech Patent Production  Barham, Foltz, and Kim 
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3.   Data on Ag-Biotech Patenting: 
 
The patent data used here come from a search of the 
U.S. Patent office database for university owned utility 
patents that were both agricultural and biotechnological.
3  
We considered all patents in U.S. classes 435, 800, 935 
as biotech and then searched within them for those that 
were agricultural.  The definition of agriculture we used 
required that the technology: 1) uses extensively a 
product produced on a farm; or 2) modifies or improves 
a product produced on a farm; or 3) modifies, improves, 
or produces a food, wood, or aquaculture product.  Note 
that this definition excludes a number of technologies 
including: (i) any animals or plants produced entirely for 
research purposes (e.g., mice, rats, monkeys); (ii) any 
animal primarily designed as a pet: e.g. dogs and cats; 
(iii) any product that merely uses animal or plant cells in 
minor quantities for a non-agricultural product; or (iv) 
any vaccine or vaccine technique or disease diagnostic 
technique that is intended primarily for use in humans, 
or on human diseases, or on diseases not currently 
treated in animals.  Note that the database does include 
utility patents on plants intended only for ornamentation 
so long as they fit the definition of being biotechnology.   
The search yielded 795 ag-biotech patents in total 
owned by 107 different universities as of the summer of 
2000.  It is worth noting that patents represent only a 
small component of the research output of universities.  
Thus, the ag-biotech patent numbers are not meant to 
represent overall university ag-biotech research output.  
They do, however, provide an accurate measure of the 
intellectual property rights owned by a university in ag-
biotech and are likely in most cases to be strongly 
correlated with overall research production in this arena. 
The patent data were then used to search for 
citations. Studies of patent citations have shown that 
they do provide a reasonable proxy for both quality of a 
patent and knowledge spillovers from it, because each 
time a new patent uses a piece of research from another 
patent it is obligated to cite the previous patent (Jaffe, 
Trajtenberg and Henderson; and Henderson, Jaffe, and 
Trajtenberg).  Thus, at a minimum, a patent citation 
suggests a knowledge spillover (either direct or indirect) 
and often suggests that some royalties or licensing 
revenues are being or will later be paid.   
For each identified university patent, we searched 
the U.S. Patent Office database for citations of those 
                                                 
3 Plant patents, under the plant variety protection act, were 
excluded because they represent a much lower level of 
intellectual property protection as well as lower levels of 
novelty required for a successful application. 
patents.  Each of the citing patents was then retrieved to 
check whether it was (1) by the same authors, (2) owned 
by a university or business or foreign economic agent
4, 
and, (3) whether either the authors or the assignee 
(university or company) of the citing patent was in the 
same state as the original patent owner.  We can thus 
distinguish between different types of in-state citations: 
those made by the same researchers, those assigned to 
the same university with different authors, those 
assigned to a business in-state or business patents with 
in-state inventors, and those assigned to another 
university in-state.  The last category has very few 
observations.   
 
4. Empirical  Evidence 
 
4.1 Key Trends in U.S. University Ag-Biotech Patent 
Production  
Judging by the recent explosion of accepted patents 
among land-grant universities in the United States, the 
long-touted ag-biotech revolution is underway. As 
shown in Figure 1, the actual number of U.S. university-
owned ag-biotech patents accelerated gradually from 
around 10 granted per year at the outset of the 1980s to 
around 25 per year in the late 1980s, early 1990s.
5  The 
breakout year was in 1996 for which 78 patents were 
granted, while 1997, 1998, and 1999 gave rise to 105, 
124, and 174 accepted patents respectively.  Thus, for 
the four latest years, the number of patents secured, 481, 
exceeds the cumulative total of 314 for the first 20 years 
of U.S. university’s ag-biotech patenting.   
 
4.2 Who are the leaders? 
The first two columns of table 1 show that the top 20 
universities, ranked by accepted ag-biotech patents 
during this time period, are, with the exception of the 
University of Pennsylvania (#17), all public land-grant 
institutions, with agricultural colleges.
6 As of the 
summer of 2000, the top five ag-biotech patent holding 
universities were, respectively, the University of 
                                                 
4 We do not distinguish between university and business 
patents for non-U.S. citations because of the different laws in 
determining what constitutes a university from a private 
company in other countries. 
5 We date patents by the year of grant unlike Foltz et al. 
(2001) and Henderson et al. (1998) who chose to date patents 
by the year of application to reduce time lags between the 
existence of new invention and grant date.  In this study by 
crediting universities in the year of the patent grant we are 
able to minimize incomplete data issues.   
6 Cornell University is both a public and private institution, 
but the agricultural college is a land-grant institution and part 
of the public component of the institution. Trends in University Ag-Biotech Patent Production  Barham, Foltz, and Kim 
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Wisconsin with 53, Cornell with 52, Iowa State with 47, 
Michigan State with 44, and the University of California 
at Davis with 32.  The next five universities, University 
of Florida, Purdue, University of Minnesota, Louisiana 
State, and North Carolina State have more than 20 ag-
biotech patents, and the 11
th-20
th all have, as it turns out, 
between 11 and 19 ag-biotech patents.  Overall, ag-
biotech patent holdings among U.S. universities are 
moderately concentrated.  The top five holders 
mentioned above have 29% of the total number of 
patents, the top 10 have 45%, and the top 20 have 63%.  
Ag-biotech patent holdings among U.S. universities are 
almost completely dominated by public land-grant 




Using 1996 as the "take-off" year, we divide the 
sample into a ranking for the whole period and one for 
the pre-take-off period up to 1995.  Over time these ag-
biotech patent production rankings show strong signs of 
persistence with a few notable changes. If one compares 
the top ranked ag-biotech patent holders during the 
1976-1995 period with that of 1976-2000, shown in 
columns 1 and 3 of Table 1, one finds several indicators 
of the persistence among the leaders: 
(1) 15 of the top 20 overall in 2000 were also in the 
top 20 in 1995.  
(2) The top 2 (University of Wisconsin and Cornell) 
have remained the same over both time periods, as they 
went from 29 and 21 patents in 1995, to 53 and 52 
respectively for the 1976-2000 time-period. 
(3) The top five ranked universities in 1995 were all 
still among the top ten over the 1976-2000 period. 
(4) All of the top-10 ranked universities in 1995 
remained in the top 20 over the 1976-2000 period. 
(5) The top five patent producers between 1996 and 
2000 were all in the top 15 in 1995. 
Among the notable changes in the top 20 rankings 
are: 
(1) The emergence of Michigan State as the most 
productive university between 1996 and 2000.  During 
this time they moved from #12 in 1995 to #4 overall, as 
they went from 7 to 44 patents. 
(2) The jump of Texas A&M (#11), Rutgers (#13), 
University of Pennsylvania (#17), University of 
Kentucky (#18), and Penn State (#20) from zero patents 
into the top 20.  
 
4.4  Determinants of Patenting Success: 
The rather strong pattern of persistence in ag-biotech 
patent production over the two time periods shown in the 
previous section is particularly noteworthy given the 
dramatic growth of patents acquired by universities over 
the past few years. This leads us to consider what 
determines ag-biotech patenting in general and the 
persistence of production in particular. This sub-section 
summarizes the major determinants of successful patent 
production using results from a dynamic count model 
reported in Foltz, Kim, and Barham.
7    
First, not surprisingly, that work finds strong 
evidence of a Land Grant effect in ag-biotech patenting.  
This means that the long-standing emphasis of Land 
Grant institutions on agricultural research and the 
associated funding provided by federal and state sources 
is a major determinant of the number of ag-biotech 
patents produced by universities.  That work also 
identified econometrically what was shown above in the 
persistence discussion, namely universities with initial 
success in obtaining ag-biotech patents tend to receive 
more patents in the future. Work on manufacturing firm 
patenting by Blundell, Griffiths, and Van Reenen shows 
a similar dynamic effect in patenting.  This finding on 
dynamic effects for university patenting underscores the 
likely existence of important learning costs for catch-up 
for universities that are not yet active in ag-biotech 
research.  The presence of university-specific effects 
characterized by the degree of investments in technology 
transfer infrastructure is also detected.  However, these 
effects are more related to the quality of investments in 
tech transfer (e.g., the university-wide ratio of invention 
disclosures turned into patents) rather than the quantity 
of investment (e.g., the size of the work force in the 
technology transfer office).  
The econometrics, however, do not reveal strong 
linkages between ag-biotech patent production and 
levels of industry funding.  In other words, industry 
funding does not seem to play a significant role in 
influencing patent production in university ag-biotech 
research.  Instead, levels of own institutional and state 
funding are the most highly correlated with ag-biotech 
patent production.  No synergy effect of having a high 
quality biology department, as measured by the number 
of biological science graduate students, was detected.   
One way of explaining this result may be that a 
necessary condition for ag-biotech patent production is 
having departmental units focused on applying 
innovation to agricultural problems, such as plant 
pathology and animal science. This result is also 
consistent with the significant Land Grant effect 
mentioned earlier.   
                                                 
7 For details on estimation approach, see Foltz, Kim and 
Barham (2001), which examines the factors that account for 
ag-biotech patenting success among universities using a 
dynamic count data model. Trends in University Ag-Biotech Patent Production  Barham, Foltz, and Kim 
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4.5 Citations – Quality, Spillovers and Local Spillovers 
4.5.1 Quality 
We use patent citation data to construct a measure 
capturing the importance of the invention conveyed by a 
patent.  Notice that this approach requires an implicit 
view of technology as an evolutionary process, in which 
the significance of a particular invention can be 
evaluated by the degree of its impacts on future 
inventions.  For example, a citation of Patent X by 
Patent Y means that X possesses a piece of knowledge 
upon which Y invented, thus indicating the significance 
of X in stimulating and facilitating the invention of Y.   
Following Henderson et al. we define a citation-
based importance measure by total citations received.   
As shown in Figure 2, across the years the number of 
total citations per patent (mean citations) varies 
approximately between 2 to 12.  The higher citation 
numbers correspond to the middle and late 1980s and 
lower numbers to the later periods of our data.  The 
recent drop-off probably represents a data artifact rather 
than an actual trend toward lower citation levels.  The 
first citations of a patent typically appear at least 3 years 
after a patent has been granted, so that we would expect 
the recent ag-biotech patents to show, on average, fewer 
citations. 
About 45 percent of the patents had received at least 
one citation by the summer of 2000, which is lower than 
the percentage (about 70-90 percent) reported in Jaffe et 
al. (1993) for their sample of all university patents.   
However, since more than half of the ag-biotech patents 
were granted in the late 1990s, a more appropriate 
comparison is with the pre-1996 data, of which 83% had 
at least one citation. The mean number of citations 
received per patent over all data periods is 2.75.  Again 
truncating our sample at 1996, however, one finds that 
the mean number of citations reaches 7.13.  This 
compares favorably to the levels, 6.12 for 1975 and 4.34 
for 1980, found by Jaffe et al. (1993) for all university 
patents, suggesting that ag-biotech patents by this 
measure may be more important research innovations 
than the average university patent.  Since most of these 
are still young patents, one can expect to see a great deal 
more citations of ag-biotech patents in the near future, 
although it is also safe to presume that citation rates on 
earlier patents may be greater. 
Table 2 presents citations of ag-biotech patents 
broken down by university.  Considering the first 
column, one notices that the top three patent producers, 
Wisconsin, Cornell, and Iowa State, are among the top 
five in producing citations. Ohio State and UC-Berkeley 
move up the rankings into the top five, although this 
may in part be due to the more advanced age of their 
patent portfolios.  Two other surprising examples in the 
data of universities with smaller, but more highly cited 
patent, portfolios are Harvard and Ohio University with 
4 and 5 ag-biotech patents respectively, but 139 and 142 
citations of those patents. The data do not show that 
universities producing a lot of ag-biotech patents are also 
producing patents of higher levels of citations than lower 
producing universities.  Estimates of the correlation of 
citations per patent and number of patents by a 
university were marginally negative (-0.07) for both the 
full and 1995 samples and not significantly different 
than zero for either one. This suggests no synergies 
between quantity and quality, as measured by citations, 
in ag-biotech patenting.  Such an outcome would be 
consistent with the common notion that a patent is like a 
lottery ticket.   
 
4.5.2 Spillovers 
Next, we investigate who cites university ag-biotech 
patents.  This may uncover some idea of the knowledge 
and economic spillover effects from university 
innovation represented by ag-biotech patents.  One needs 
to understand that the data only examine the group of 
“spillovers accompanied by citations”, even though 
some citations can occur without producing either 
knowledge or economic spillovers and some spillovers 
can occur without generating a citation.
8 As indicated in 
Table 2, more than half of the citations were made by 
businesses.  Universities accounted for about a quarter of 
the citations, followed by foreign assignees (both 
universities and businesses).
9  The residual category, not 
shown, is patents by individual unaffiliated inventors.   
Most of the top twenty producing universities had their 
ag-biotech patents cited at about the same rate by 
businesses, universities and foreign inventors.  The 
major exception is Rutgers University where 96 percent 
of the citing patents were owned by businesses.  
 
4.5.3 Local Spillovers 
Table 3 shows the proportion of these business 
citations that are localized in the same state as the 
university.  Overall, the in-state business citations 
represent only 6.8% of all citations and 13% of the 
business citations.  This demonstrates very low levels of 
                                                 
8 For details on issues relating to the use of citation data to 
infer knowledge spillovers see Jaffe et al. (1993) and Jaffe et 
al. (2000). 
9 Note that university citations include 274 self-citations—a 
citing patents assigned to the same party as the originating 
patent.  Thus, a higher proportion of citations outside the 
university are business citations of university patents, thereby 
suggesting an even stronger linkage between university 
patents and businesses than shown in the data.  Trends in University Ag-Biotech Patent Production  Barham, Foltz, and Kim 
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in-state business citations, especially when one considers 
that one institution, Iowa State, accounts for more than 
one-third of the in-state citations. Iowa State’s high level 
of localization reflects a very strong relationship 
between Pioneer Hybrid Seed Company and Iowa State 
University, rather than citations by start-up businesses.   
Overall, the evidence suggests that while strong 
links exist between university ag-biotech patents and 
businesses, the degree of localization of those links to 
date has been quite small. While these data are by no 
means definitive because ag-biotech patenting is still in 
its beginning stages, they do suggest that ag-biotech is 
not following the same pattern of agglomeration effects 
seen in pharmaceutical biotechnology.  To date, there 
seem to be relatively little new patentable research 
fostered in the proximate neighborhoods of Land Grant 
Universities.  Instead, significant local business 
spillovers seem to take place where universities happen 
to be located in the same state as a major agribusiness 
companies (e.g. Pioneer in Iowa, and J. R. Simplot in 
Idaho) rather than visa-versa.  The recent takeoff in ag-
biotech patents, however, could possibly give rise to a 
distinctive pattern of citations by local businesses, as the 
technology enters a second wave of commercial 
development.  Thus, more definitive answers to confirm 
the low degree of spillover localization found so far will 
require either more time to be revealed in the pattern of 
citations or university-level data on current start-up 
efforts. 
 
4.6  Inequality in Patent Production Lorenz Curve 
Analysis 
We use a Lorenz curve for the analysis of inequality 
among universities in ag-biotech patenting.  The analysis 
here is restricted to Land Grant Universities, because 
universities that did not engage in any agricultural 
research would overstate levels of inequality in a sample 
of all universities.  Figure 3 presents a Lorenz curve for 
university ag-biotech patenting comparing the period up 
until 1995 with the last four years.  As the Lorenz curves 
show, there is a great deal of inequality with, for the full 
timeline, the top 10% of universities owning more than 
35% of the patents and the top 20% owning almost 60%.  
While patenting in the last four years has become mildly 
less concentrated as more universities participate, the top 
universities still own a disproportionate number of ag-
biotech patents.   
Figure 4 uses citation counts in an attempt to adjust 
the patents for quality differences.  These data show 
higher degrees of inequality, with even higher levels of 
inequality for recent patents.  This finding suggests that 
the differences in patent quality are higher than those for 
measures of total patents.  If that quality difference were 
also to show up in differences in patenting revenues, 
then one could expect to see increasing differences in 
university funding levels.  This concern, however, can 
be partially tempered by our finding of no correlation 
between patent quantities and qualities. 
Finally, we compare, in Figure 5, Lorenz curves for 
ag-biotech patenting to ones for agricultural college 
funding and numbers of graduate students in agricultural 
sciences.  The figure shows that ag-biotech patenting to 
date has been more unequally distributed among 
universities than has either overall agricultural science 
funding or graduate student numbers.  However, these 
differences between patenting and financing are not 
large.  Whether they will persist is also unclear, 
especially if the recent widening in patent production 
continues.  While not definitive, the evidence so far 
suggests that university ag-biotech patenting at the very 
least is not diminishing inequality among Land Grant 
Universities and, if the imbalance in citations turns out 
to reflect revenue streams from ag-biotech research, may 
be increasing it.  
 
5.  Concluding Remarks  
 
The time is ripe for empirical work that can inform 
land-grant university researchers and administrators as 
they participate in public policy discussions on how ag-
biotech research and development should unfold in the 
U.S. and internationally.  Luckily, as demonstrated in 
this paper, the ready availability of secondary sources of 
data, such as those from the U.S. Patent Office, make 
such research less complicated than is often imagined.  
The data provide a way to get started on the debate, by 
imparting key information needed to better understand 
trends in university ag-biotech research, patenting, and 
citations.  
This study of university ag-biotech patents offers 
many useful lessons beyond simply identifying the scope 
of activity to date.  One is the strong evidence for 
persistence in ag-biotech patent production.  That 
finding bodes poorly for universities not already active 
in this arena that might be pursuing a catch-up strategy.  
So does the fact that both patents and citations are 
somewhat more concentrated among the leading Land 
Grant Universities than are research funding and 
graduate student enrollments in agricultural sciences.   
This finding buttresses the concerns of the potential that 
ag-biotech has for deepening the existing inequality 
among major and minor Land Grant Universities.   
One finding from the patent and citation data, 
however, somewhat counterbalances potential concerns 
about persistence and inequality.  We find no 
relationship between the quantity of patents held by a Trends in University Ag-Biotech Patent Production  Barham, Foltz, and Kim 
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university and the importance of those patents, as 
indicated by the number of citations received.  In other 
words, there seems to be an equal chance that a given 
patent will turn out to be a major discovery regardless of 
whether a university is a minor or major player in ag-
biotech patenting.  This suggests that patents are much 
like lotteries, where the probability of winning goes up 
with the number of tickets held but not the probability of 
any given ticket being a winner.  While it is still too 
early to judge economic returns to university ag-biotech 
patents, the high citation rates suggest they are relatively 
more important for the research community than other 
university patents.  
In terms of the potential spillover effects of ag-
biotech patents, the citation data show that, while strong 
links exist between university ag-biotech patents and 
businesses, the degree of localization of those links to 
date may be quite small. Put differently, major 
international firms are the main businesses citing 
university ag-biotech patents.  While not yet definitive, 
our research suggests that if university ag-biotech is 
going to generate significant local spillovers in the form 
of start-up companies to the extent that computers or 
pharmaceuticals have, it will have to occur in the 
subsequent rounds of patenting, because it has not 
occurred yet.  
This analysis of U.S. patent data has offered 
preliminary evidence on several pressing questions in 
university ag-biotech patenting, but more research and 
data are needed.  First, in focussing on patents, this 
inquiry has ignored the value of other ag-biotech 
research output, such as published papers, conference 
presentations, improved technical infrastructure, and a 
community of informed and skilled researchers and 
students.  Second, while this work has used citations as a 
measure of quality, future research could improve on 
patent and citation measures with data on licensing 
revenues and university involvement in start-up 
companies.  Finally, it remains to be seen to what extent 
commercial motives, either through direct industry 
financing or through the promise of patent revenues, 
influence the research at Land Grant Universities to be 
more applied and aimed at patents rather than toward 
basic fundamental research.  Future research that 
investigated these issues would help further the debate. 
While certainly not definitive, our analysis provides 
some guidance to federal and state policy makers and 
university administrators, as they develop policies and 
make investments in research.  National policy makers 
should be heartened by the recent "take-off" in 
university ag-biotech research, the high quality of the 
patents, and the national public-good nature of the 
patents.  On the national scale, however, additional 
support for new entrants and minor players in ag-biotech 
research may be warranted, since our results show that 
patenting in agricultural colleges is likely to foster 
inequalities among universities in part because of its 
path dependent feature.   
In choosing among different potential focuses for 
university research, the higher average citation rate for 
ag-biotech patents compared to other university patents 
suggests that ag-biotech research may be a more 
valuable lottery to invest in than other types of patented 
research.  Yet, the national or even international nature 
of spillovers or public goods created by university ag-
biotech research to date raises questions about the likely 
efficacy of ongoing efforts by state governments to 
encourage local ag-biotech business ventures through 
sponsoring university research in this arena of inquiry.  
Ag-biotech patenting would seem to be a good 
investment, but policy makers should be aware that the 
benefits will not be equally distributed and may not land 
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 Table 1. University Ag-Biotech Patent Rankings 










U. of Wisconsin  1  53  1  29 
Cornell  2 52 2 21 
Iowa State                   3  47  5  11 
Michigan State               4  44  12  7 
UC-Davis 5  32  15  7 
U. of Florida                       6  29  3  14 
Purdue  7 26 4 13 
U. of Minnesota                     8  26  14  7 
Louisiana State             9  24  9  8 
North Carolina State  10  21  7  10 
Texas A&M  11  19  .  0 
UC-Berkeley  12  19 6 11 
Rutgers 13  18  .  0 
U. of Georgia                       14  17  10  8 
Oregon State          15  14  8  10 
U. of Maryland 16  13  11  8 
U. of Pennsylvania                  17  13  .  0 
U. of Kentucky   18  12  .  0 
Ohio State                   19  11  13  7 
Penn State   20  11  .  0 
Total    795  294 
 Trends in University Ag-Biotech Patent Production  Barham, Foltz, and Kim 
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Citations  No.  % No. %  No.  % 
U. of Wisconsin  186  93  50.0  74  39.8  15  8.1 
Cornell 101  51  50.5  26  25.7  17  16.8 
Iowa State  124  74  59.7  30  24.2  11  8.9 
Michigan State   37  18  48.6  13  35.1  4  10.8 
UC-Davis 47  13  27.7  14  29.8  19  40.4 
U. of Florida                       81  51  63.0  20  24.7  9  11.1 
Purdue 76  44  57.9  14  18.4  15  19.7 
U. of Minnesota                    51  30  58.8  13  25.5  6  11.8 
Louisiana State   37  13  35.1  20  54.1  4  10.8 
North Carolina State   43  11  25.6  19  44.2  12  27.9 
Texas A&M  45  23  51.1  19  42.2  3  6.7 
UC-Berkeley 82  46  56.1  14  17.1  15  18.3 
Rutgers 75  72  96.0  0  0.0  1  1.3 
U. of Georgia                       33  14  42.4  6  18.2  11  33.3 
Oregon State  51  23  45.1  10  19.6  14  27.5 
U. of Maryland  24  10  41.7  8  33.3  4  16.7 
U. of Pennsylvania                3  1  33.3  1  33.3  0  0.0 
U. of Kentucky   12  5  41.7  5  41.7  1  8.3 
Ohio State  136  60  44.1  33  24.3  30  22.1 
Penn State   5  1  20.0  1  20.0  3  60.0 
Total 2188  1142  52.2  567  25.9  336  15.4 Trends in University Ag-Biotech Patent Production  Barham, Foltz, and Kim 
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Table 3: Localization of Business Citations 
Business 
Out of State  In State  Total 
 
University 
No. %  No.  %  No.  % 
U. of Wisconsin  83  44.6  10  5.4  93  50.0 
Cornell  46 45.5 5 5.0 51  50.5 
Iowa  State  21  16.9 53  42.7 74 59.7 
Michigan  State    18 48.6 0 0.0 18  48.6 
UC-Davis 6  12.8  7  14.9  13  27.7 
U. of Florida                       49  60.5  2  2.5  51  63.0 
Purdue  44 57.9 0 0.0 44  57.9 
U. of Minnesota                    27  52.9  3  5.9  30  58.8 
Louisiana  State  12 32.4 1 2.7 13  35.1 
North Carolina State   9  20.9  2  4.7  11  25.6 
Texas  A&M  21 46.7 2 4.4 23  51.1 
UC-Berkeley 37  45.1  9  11.0  46  56.1 
Rutgers  72 96.0 0 0.0 72  96.0 
U. of Georgia                       14  42.4  0  0.0  14  42.4 
Oregon State   22  43.1  1  2.0  23  45.1 
U. of Maryland  9  37.5  1  4.2  10  41.7 
U. of Pennsylvania                0  0.0  1  33.3  1  33.3 
U. of Kentucky   5  41.7  0  0.0  5  41.7 
Ohio  State  59 43.4 1 0.7 60  44.1 












Total  993  45.4 149 6.8 1142  52.2 Trends in University Ag-Biotech Patent Production  Barham, Foltz, and Kim 
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Figure 5. Lorenz Curves For Ag-Biotech Patents, Agricultural Graduate Students  
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